KEY SERVICES
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
01 1TAPI Technology & API Services
01 1DESVENLAFAXINE BASE
01 1Israel
01 1Active
01 1Complete
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : Complete
Rev. Date : 2024-06-24
Pay. Date : 2024-06-17
DMF Number : 26357
Submission : 2012-08-26
Status : Active
Type : II
20
Tapi Nl Bv, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
One of their notable products is DESVENLAFAXINE BASE, with a corresponding US DMF Number 26357.
Remarkably, this DMF maintains an Active status since its submission on August 26, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 24, 2024, and payment made on June 17, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II
